Clinical Trial Update: First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating BuMA Supreme and Resolute Integrity in de novo coronary artery stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BuMA Supreme
• Resolute Integrity

Snippet

Sponsor: Sino Medical Sciences Technology Inc. | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED